Younger patients - aged 50 to 64 - are more likely to be diagnosed with late stage lung cancer than older patients according to new data* being presented at the Cancer Outcomes and Data Conference** in Manchester today (Tuesday).
The new analysis shows that between the ages of 50 and 64, a higher proportion of patients were diagnosed at a late stage of lung cancer compared to patients aged 65-69.
People in their 70s are more likely to be diagnosed with early stage disease.
Researchers examined the records of around 34,000 lung cancer patients in England in 2013 to explore the association of early and late stage lung cancer and age.
Previous research shows that older patients may be diagnosed with certain cancers such as bladder and lung at an earlier stage compared to younger patients, but this is the first time this relationship has been explored using lung cancer data at a national level.
David Kennedy, Cancer Research UK's data and research analyst, said: "Through harnessing the power of patient data we were able to detect this difference in the stage at which younger and older people are diagnosed with this disease. Our results show that younger patients in their 50s and early 60s are more likely to be diagnosed with advanced lung cancer compared to patients in older age groups. Further analysis will focus on understanding this relationship to see if a similar pattern is present for other types of cancer."
There are around 45,500 cases of lung cancer diagnosed in the UK every year**. Around six in 10 cases are in people over 70. Most lung cancer cases are diagnosed at a late stage.
Dr Julie Sharp, Cancer Research UK's head of health and patient information, said: "This research is a great example of the importance of good quality data. It can lead to a better understanding of who is at an increased risk of different cancers. It can help target resources to the right groups in helping to improve cancer survival.
"It's not clear exactly why younger patients are more likely to be diagnosed with advanced lung cancer, but what's important is that the disease is caught early. Signs of lung cancer can include a cough that won't go away or being short of breath. It's vital that when people spot something unusual for them, they go to their doctor as soon as possible. Detecting cancer early is crucial as it offers the best chance of successfully treating the disease."
For media enquiries contact Paul Thorne in the Cancer Research UK press office on 020 3469 or, out of hours, on 07050 264 059.
* Investigating the relationship between age and stage at diagnosis for lung cancer
* The PHE National Cancer Registration and Analysis Service (NCRAS) Cancer Data and Outcomes Conference 2016 is taking place on 13 and 14 June. It explores how data is being used to drive services both locally and nationally and highlights how cancer data is improving the prevention, diagnosis, treatment and outcomes of cancer in the UK and beyond.
* In February 2016 PHE's National Cancer Registry Service and the National Cancer Intelligence Network came together to form the National Cancer Registration and Analysis Service (NCRAS). NCRAS collects and quality assures all cancer data in England and uses analysis and intelligence to drive improvements in prevention, standards of cancer care and clinical outcomes for cancer patients.
*** Number of new cases diagnosed in the UK from lung cancer (ICD10 C33-34) in 2013. More people with a known stage are diagnosed at an advanced stage (77% diagnosed at stage III or IV) than an early stage (23% diagnosed at stage I or II).
For the latest lung cancer statistics visit: http://www.
About Cancer Research UK
- Cancer Research UK is the world's leading cancer charity dedicated to saving lives through research.
- Cancer Research UK's pioneering work into the prevention, diagnosis and treatment of cancer has helped save millions of lives.
- Cancer Research UK receives no government funding for its life-saving research. Every step it makes towards beating cancer relies on every pound donated.
- Cancer Research UK has been at the heart of the progress that has already seen survival in the UK double in the last forty years.
- Today, 2 in 4 people survive their cancer for at least 10 years. Cancer Research UK's ambition is to accelerate progress so that 3 in 4 people will survive their cancer for at least 10 years by 2034.
- Cancer Research UK supports research into all aspects of cancer through the work of over 4,000 scientists, doctors and nurses.
- Together with its partners and supporters, Cancer Research UK's vision is to bring forward the day when all cancers are cured.
For further information about Cancer Research UK's work or to find out how to support the charity, please call 0300 123 1022 or visit http://www.